These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 24165680)

  • 1. mTOR complexes in neurodevelopmental and neuropsychiatric disorders.
    Costa-Mattioli M; Monteggia LM
    Nat Neurosci; 2013 Nov; 16(11):1537-43. PubMed ID: 24165680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR in health and in sickness.
    Liko D; Hall MN
    J Mol Med (Berl); 2015 Oct; 93(10):1061-73. PubMed ID: 26391637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR in Brain Physiology and Pathologies.
    Bockaert J; Marin P
    Physiol Rev; 2015 Oct; 95(4):1157-87. PubMed ID: 26269525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mTOR signaling: at the crossroads of plasticity, memory and disease.
    Hoeffer CA; Klann E
    Trends Neurosci; 2010 Feb; 33(2):67-75. PubMed ID: 19963289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic target of rapamycin complex 2 protects the heart from ischemic damage.
    Völkers M; Konstandin MH; Doroudgar S; Toko H; Quijada P; Din S; Joyo A; Ornelas L; Samse K; Thuerauf DJ; Gude N; Glembotski CC; Sussman MA
    Circulation; 2013 Nov; 128(19):2132-44. PubMed ID: 24008870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian target of rapamycin (mTOR) pathways in neurological diseases.
    Wong M
    Biomed J; 2013; 36(2):40-50. PubMed ID: 23644232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal mTOR Activation in Autism.
    Winden KD; Ebrahimi-Fakhari D; Sahin M
    Annu Rev Neurosci; 2018 Jul; 41():1-23. PubMed ID: 29490194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recollection of mTOR signaling in learning and memory.
    Graber TE; McCamphill PK; Sossin WS
    Learn Mem; 2013 Sep; 20(10):518-30. PubMed ID: 24042848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin.
    Zou Z; Chen J; Yang J; Bai X
    Curr Cancer Drug Targets; 2016; 16(4):288-304. PubMed ID: 26563881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mTOR Complexes in Neurogenesis.
    LiCausi F; Hartman NW
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29789464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurology of mTOR.
    Lipton JO; Sahin M
    Neuron; 2014 Oct; 84(2):275-91. PubMed ID: 25374355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoregulation of the mechanistic target of rapamycin (mTOR) complex 2 integrity is controlled by an ATP-dependent mechanism.
    Chen CH; Kiyan V; Zhylkibayev AA; Kazyken D; Bulgakova O; Page KE; Bersimbaev RI; Spooner E; Sarbassov DD
    J Biol Chem; 2013 Sep; 288(38):27019-27030. PubMed ID: 23928304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic / mammalian target protein of rapamycin signaling in hematopoietic stem cells and leukemia.
    Hirao A; Hoshii T
    Cancer Sci; 2013 Aug; 104(8):977-82. PubMed ID: 23648144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and pharmacologic evidence that mTOR targeting outweighs mTORC1 inhibition as an antimyeloma strategy.
    Chen X; Díaz-Rodríguez E; Ocio EM; Paiva B; Mortensen DS; Lopez-Girona A; Chopra R; Miguel JS; Pandiella A
    Mol Cancer Ther; 2014 Feb; 13(2):504-16. PubMed ID: 24431075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.
    Gordon BS; Kazi AA; Coleman CS; Dennis MD; Chau V; Jefferson LS; Kimball SR
    Cell Signal; 2014 Mar; 26(3):461-7. PubMed ID: 24316235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic modeling of signal transduction by mTOR complexes in cancer.
    Dorvash M; Farahmandnia M; Mosaddeghi P; Farahmandnejad M; Saber H; Khorraminejad-Shirazi M; Azadi A; Tavassoly I
    J Theor Biol; 2019 Dec; 483():109992. PubMed ID: 31493485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR has a developmental stage-specific role in mitochondrial fitness independent of conventional mTORC1 and mTORC2 and the kinase activity.
    Kalim KW; Zhang S; Chen X; Li Y; Yang JQ; Zheng Y; Guo F
    PLoS One; 2017; 12(8):e0183266. PubMed ID: 28813526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrient signaling to mTOR and cell growth.
    Jewell JL; Guan KL
    Trends Biochem Sci; 2013 May; 38(5):233-42. PubMed ID: 23465396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.
    Kaur A; Sharma S
    Inflammopharmacology; 2017 Jun; 25(3):293-312. PubMed ID: 28417246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.